Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 51655-934

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 51655-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-934-52 (51655 934 52 Rev A 09 22)

51655-934-52 (51655 934 52   Rev A 09 22)
Label for metoprolol succinate extended-release tablets, USP, 25 mg strength. The film-coated oral tablets come in a package of 30. The label includes storage instructions and manufacturer information, indicating Northwind Pharmaceuticals USA, Inc. as the repackager. The label shows the product NDC 51655-934-52.*
FDA Label Image

2 (Image 5)

2 (Image 5)
Chemical structure diagram of metoprolol succinate, showing the molecular components including a substituted aromatic ring and succinate moiety. The structure includes phenyl, ether, alcohol, amine groups, and succinic acid component.*
FDA Label Image

1 (Image 6)

1 (Image 6)
A forest plot showing subgroup analysis results from the MERIT-HF study evaluating metoprolol succinate extended-release versus placebo. The plot depicts relative risk and 95% confidence intervals for Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality Hospitalization for Heart Failure across various patient subgroups such as region, NYHA class, ejection fraction, sex, race, prior medical history, and heart rate.*
FDA Label Image

Image 1 (Image 7)

Image 1 (Image 7)
The packaging label shows metoprolol succinate 25 mg extended-release film-coated tablets. The box displays the product name and strength prominently, with the dosage form and labeler Northwind Health Company, LLC identified. The label includes the product NDC number 51655-934 and indicates oral administration. The packaging is primarily white with blue and green accents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.